ArticleJournal of translational medicine2024

C188-9 reduces patient-specific primary breast cancer cells proliferation at the low, clinic-relevant concentration.

Rongji Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.